跳至主要内容
临床试验/NCT03516474
NCT03516474Unknown不适用

Minimally Disruptive Medicine: Reducing Treatment Burden and Improving Access for All Patients With Diabetes Using an mHealth Strategy

Unity Health Toronto0 个研究点目标入组 400 人开始时间: 2018年5月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
400
主要终点
Lower rates of DFU recurrence in patients monitored using mHealth

研究概览

简要总结

In this study the investigators are testing a device that may help us tell how well the participants' wound is healing. This device is called the MIMOSA, and it shines different "colours" of light on the participants' skin. It will not touch the participants' skin, or change how the participants' wound is healing. The MIMOSA is designed to be used alongside the camera that is built into the participants' cell phone, and the investigators will use a cell phone to take a picture of the participants' skin. This picture will tell us how much oxygen is getting to the participants' wound, which can tell us more about how the participants are healing. The MIMOSA device is an experimental diagnostic tool, and will not influence how the participants' wound is healing.

详细描述

The investigators have developed a tool called the MultIspectral MObile TiSsue Assessment (MIMOSA) Device, which attaches to a smartphone and assesses tissue health parameters in a quick, non-invasive way using near-infrared light. This study will use MIMOSA to monitor patients at 4 sites in Toronto (St. Michael's Hospital, Women's College Hospital, South Riverdale Community Health Centre and at Westpark Healthcare Centre). These study sites were chosen to cover patients from diverse clinical backgrounds: St. Michael's Hospital is an Acute care centre for the diabetic lower extremity, Women's College Hospital is an outpatient wound clinic focused on the management of DFUs, South Riverdale is a Community Health Centre focused on prevention, and Westpark is a rehabilitation site focused on post-operative/amputation care and preservation of the opposite limb. conducted on patients who present with a non-healing diabetic foot ulcer and are already receiving standard best practice as prescribed by the diabetic foot multi-disciplinary team.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetes: Type I or Type II.
  • Outpatient or inpatient
  • Diabetic Foot Ulcer
  • Adhere to monitoring schedule

排除标准

  • Presence of invasive infection requiring intravenous antibiotics
  • Cognitively able to give consent & participate in study
  • Active malignancy
  • End stage renal disease
  • Patients who are participating in another clinical study for ulcer management
  • Patients with a known history of poor compliance with medical treatment
  • Patients who are unable to understand the aims of the study and not give informed consent

结局指标

主要结局

Lower rates of DFU recurrence in patients monitored using mHealth

时间窗: 0-12 months

Accurately recorded pictures and information will help clinicians to accurately access patient foot health and hopefully reduce the frequency of DFU's using this information.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Using mHealth to Modernize Diabetes Care | 临床试验